Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00216
|
|||||
| Drug Name |
Betrixaban
|
|||||
| Synonyms |
74RWP7W0J9; Betrixaban (USAN); Betrixaban [USAN:INN]; Bevyxxa; D0J0BU; EX-A358; GTPL9602; MolPort-009-682-948; PRT 054021; PRT054021; QCR-99; SCHEMBL158591; UNII-74RWP7W0J9; ZINC3; betrixaban maleate; betrixaban/
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Venous thromboembolism [ICD11: BD72] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H22ClN5O3
|
|||||
| Canonical SMILES |
CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl
|
|||||
| InChI |
InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)
|
|||||
| InChIKey |
XHOLNRLADUSQLD-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 330942-05-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 451.9 | Topological Polar Surface Area | 107 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
3.6
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:140421
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Betrixaban was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism. Vasc Health Risk Manag. 2015 Jun 26;11:343-51. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.